of pyridinium salt 5 which was formed from 150 mg (0.565 mmol)
of 4-methoxy-3-(triisopropylsilyl)pyridine and 96.4 mg (0.565
mmol) of benzyl chloroformate in toluene at -23 °C for 40 min.
After 2 h, 15 mL of aqueous 10% HCl was added, and the
mixture was allowed to warm to rt. The mixture was extracted
with ethyl acetate. The organic extracts were dried over MgSO4
and concentrated under reduced pressure. The residue was
purified by radial PLC (silica gel, EtOAc/hexanes) to give 266
mg (78%) of 13 as a colorless solid: mp 116-117 °C; IR (thin
135.0, 135.2, 138.3, 147.5, 152.6, 195.3. Anal. Calcd for
36H42N2O5SSi: C, 67.26; H, 6.59; N, 4.36. Found: C, 67.37; H,
6.68; N, 4.33.
C
(2S*- a n d 2R*)-2-(3-In d olyl)-1-[((1R*,2S*)-2-(1-m eth yl-1-
p h en yleth yl)cycloh exyloxy)ca r bon yl]-5-(tr iisop r op ylsilyl)-
2,3-d ih yd r o-4-p yr id on es (22). To a solution of 200 mg (1.71
mmol) of indole in 25 mL of THF was added dropwise 0.57 mL
of a 3 M solution of MeMgBr. The resulting mixture was heated
to reflux for 1 h and cooled to rt. The resulting mixture was
cannulated into a solution (-78 °C) of pyridinium salt 21 which
was formed from 150 mg (0.565 mmol) of 4-methoxy-3-(triiso-
propylsilyl)pyridine and 0.57 mL of a 1 M solution of (1R*,2S*)-
2-(R-cumyl)cyclohexyl chloroformate in toluene at -23 °C for 40
min. After 2 h, 35 mL of aqueous 10% HCl was added, and the
mixture was allowed to warm to rt. The mixture was extracted
with ethyl acetate. The organic extracts were dried over MgSO4,
concentrated under reduced pressure, and the residue was
purified by radial PLC (silica gel, EtOAc/hexanes). The first
product to elute (173 mg, 50%) was identified as the major
diastereomer 22a : white solid; mp 162-163 °C; IR (thin film)
1
film) 2936, 1728, 1661, 1578, 1453, 1327, 1298, 1240 cm-1; H
NMR (CDCl3, 300 MHz) δ 1.05 (m, 18H), 1.31 (m, 3H), 1.64 (s,
9H), 2.87 (d, 1H, J ) 16.0 Hz), 3.13 (dd, 1H, J ) 16.0, 7.7 Hz),
5.21 (m, 2H), 6.36 (s, 1H), 6.54 (d, 1H, J ) 7.2 Hz), 7.25 (m,
8H), 8.04 (d, 1H, J ) 8.2 Hz), 8.17 (s, 1H); 13C NMR (CDCl3, 75
MHz) δ 11.4, 18.9, 19.1, 28.3, 41.8, 52.0, 69.2, 85.0, 107.7, 112.2,
116.1, 120.6, 123.3, 124.5, 127.9, 128.7, 128.8, 135.2, 137.1, 138.0,
148.1, 150.3, 195.7. Anal. Calcd for C35H46N2O5Si: C, 69.73; H,
7.69; N, 4.65. Found: C, 69.85; H, 7.75; N, 4.56.
1-[(Ben zyloxy)ca r bon yl]-2-(3-in d olyl)-5-(tr iisop r op ylsi-
lyl)-2,3-d ih yd r o-4-p yr id on e (14). To a stirred solution of 40
mg (0.066 mmol) of 13 in 15 mL of CH2Cl2 was added 61 mg
(0.531 mmol) of TFA. The resulting mixture was stirred for 3 h
at rt, quenched with saturated NaHCO3, and extracted with CH2-
Cl2. The combined organic extracts were dried over MgSO4 and
concentrated under reduced pressure. The residue was purified
by radial PLC (silica gel, EtOAc/hexanes) to afford 31 mg (94%)
of 14 as a white foam: IR (neat) 3392, 2940, 2868, 1720, 1664,
1571, 1453, 1387, 1335, 1305, 1253 cm-1; 1H NMR (CDCl3, 300
MHz) δ 0.97 (d, 9H, J ) 7.5 Hz), 1.03 (d, 9H, J ) 7.5 Hz), 1.27
(m, 3H), 2.90 (d, 1H, J ) 16.1 Hz), 3.11 (dd, 1H, J ) 16.1, 7.2
Hz), 5.29 (d, 1H, J ) 11.7 Hz), 5.46 (d, 1H, J ) 11.7 Hz), 6.39 (s,
2H), 7.07 (t, 1H, J ) 7.7 Hz), 7.17 (t, 1H, J ) 7.5 Hz), 7.42 (m,
6H), 7.52 (d, 1H, J ) 7.7 Hz), 7.70 (s, 1H), 8.67 (br s, 1H); 13C
NMR (CDCl3, 75 MHz) δ 11.3, 18.9, 40.1, 50.4, 69.7, 102.7, 111.0,
112.1, 120.2, 121.1, 122.9, 127.6, 128.4, 128.8, 129.1, 135.0, 135.3,
136.1, 145.6, 154.0, 196.0; HRMS calcd for C30H38N2O3Si 503.2730
[M + H]+, found 503.2730 [M + H]+.
1
3359, 2931, 1712, 1648, 1568, 1322, 1290, 1242 cm-1; H NMR
(CDCl3, 300 MHz) δ 0.80-1.61 (m, 34H), 1.97 (m, 2H), 2.42 (m,
1H), 2.72 (m, 1H), 4.19 (m, 1H), 4.78 (m, 1H), 6.71 (s, 1H), 7.18
(m, 4H), 7.39 (m, 5H), 7.96 (s, 1H), 8.06 (br s, 1H); 13C NMR
(CDCl3, 75 MHz) δ 11.4, 19.1, 21.5, 24.7, 25.9, 26.9, 31.1, 32.7,
39.7, 42.7, 48.9, 51.1, 78.3, 110.4, 111.4, 114.7, 119.2, 119.7,
120.8, 122.4, 125.3, 125.5, 128.4, 136.3, 148.3, 153.0, 153.1, 196.8.
Anal. Calcd for C38H52N2O3Si: C, 74.47; H, 8.55; N, 4.57.
Found: C, 74.41; H, 8.60; N, 4.62.
The second product to elute (112 mg, 32%) was identified as
the minor diastereomer 22b: white solid; mp 173-174 °C; IR
(thin film) 3359, 2942, 1717, 1653, 1568, 1322, 1285, 1253 cm-1
;
1H NMR (CDCl3, 300 MHz) δ 1.46 (m, 37H), 2.78 (d, 1H, J )
15.6 Hz), 3.07 (dd, 1H, J ) 15.6, 6.7 Hz), 4.94 (m, 1H), 5.96 (d,
1H, J ) 6.4 Hz), 6.91 (s, 1H), 7.20 (m, 7H), 7.60 (m, 1H), 7.74
(d, 1H, J ) 7.5 Hz), 8.07 (s, 1H); 13C NMR (CDCl3, 75 MHz) δ
11.5, 19.2, 24.7, 25.7, 26.9, 27.3, 34.1, 40.3, 42.7, 49.7, 51.6, 78.3,
110.6, 111.4, 114.4, 119.5, 120.1, 122.1, 122.6, 125.5, 125.7, 125.9,
128.2, 136.4, 147.6, 150.7, 151.9, 197.0. Anal. Calcd for
1-[(Ben zyloxy)car bon yl]-2-[1-(ph en ylsu lfon yl)-3-in dolyl]-
5-(tr iisop r op ylsilyl)-2,3-d ih yd r o-4-p yr id on e (16). To a solu-
tion of 390 mg (0.734 mmol) of 3-iodo-1-phenylsulfonylindole7
in 20 mL of THF was added dropwise 1.00 mL of a 1 M solution
of EtMgBr. The resulting mixture was stirred for 1 h at rt. The
mixture was cannulated into a solution (-40 °C) of pyridinium
salt 5, which was formed from 135 mg (0.509 mmol) of 4-meth-
oxy-3-(triisopropylsilyl)pyridine and 87.0 mg (0.509 mmol) of
benzyl chloroformate in toluene at -23 °C for 40 min. After 2 h,
20 mL of aqueous 10% HCl was added, and the mixture was
allowed to warm to rt. The mixture was extracted with ethyl
acetate. The organic extracts were dried over MgSO4 and
concentrated under reduced pressure. The residue was purified
by radial PLC (silica gel, EtOAc/hexanes) to give 309 mg (94%)
of 16 as a white solid: mp 136-137 °C; IR (thin film) 2944, 2860,
C
38H52N2O3Si: C, 74.47; H, 8.55; N, 4.57. Found: C, 74.30; H,
8.59; N, 4.48.
Ack n ow led gm en t. We express appreciation to the
National Institutes of Health (Grant GM 34442) for
financial support of this research. NMR and mass
spectra were obtained at NCSU instrumentation labo-
ratories, which were established by grants from the
North Carolina Biotechnology Center and the National
Science Foundation (Grants CHE-9509532 and CHE-
0078253).
1725, 1664, 1572, 1447, 1378, 1280, 1241, 1175, 1119, 1019 cm-1
;
1H NMR (CDCl3, 300 MHz) δ 1.06 (m, 18H), 1.32 (m, 3H), 2.72
(d, 1H, J ) 15.4 Hz), 3.14 (dd, 1H, J ) 15.4, 7.2 Hz), 5.22 (s,
2H), 5.96 (d, 1H, J ) 5.9 Hz), 7.19-7.51 (m, 12H), 7.79 (d, 2H,
J ) 7.7 Hz), 7.92 (d, 1H, J ) 8.2 Hz), 8.04 (s, 1H); 13C NMR
(CDCl3, 75 MHz) δ 11.3, 19.0, 41.7, 49.5, 69.3, 111.9, 113.9, 119.7,
120.5, 123.1, 123.6, 125.4, 126.9, 128.2, 128.6, 128.8, 129.5, 134.1,
Su p p or tin g In for m a tion Ava ila ble: Experimental pro-
1
cedure for compounds 23-25 and copies of H and 13C NMR
spectra for 8, 11, 14, and 23b. This material is available free
J O049943V
2866 J . Org. Chem., Vol. 69, No. 8, 2004